Annual Financial Results as of December 31, 2017
30/04/2018 – AB Science reports on its annual financials as of 31 December 2017 and provides an update on its activities.
CHMP has adopted a negative opinion for the marketing authorization of masitinib in Amyotrophic Lateral Sclerosis
19/04/2018 – AB Science will provide additional data through a reexamination procedure
A Modern View of Liberalism
Praesent nec lectus eu neque fringilla volutpat. Nulla tristique ullamcorper quam, ut dapibus massa hendrerit ac. Etiam a tempus lectus. Proin nibh nisi, vehicula non enim sed, venenatis faucibus orci. Fusce ut elementum nunc, vel eleifend sem.
Career Advancement Launches New Grant Program in Memory of Pat Rosenzweig
Suspendisse ex justo, lacinia nec iverra bel, lacinia id lorem. Sed turpis eget sem accumsan viverra
Defeating the Dakota Access Pipeline at Standing Rock
Nulla dui fusce feugiat malesuada odiorbi nunc odio gravida at cursus nec luctus a lorem aecenas tristique orci acsemuis ultricies pharetra magna.